Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer

Neoadjuvant cisplatin-based chemotherapy for muscle-invasive bladder cancer (MIBC) is more beneficial for clinical T3/4 than clinical T2 (cT2) disease. The aim of this study was to assess whether neoadjuvant GCarbo has a survival impact on cT2 bladder cancer. We retrospectively reviewed the medical...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Koie, Takuya, Ohyama, Chikara, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Yoneyama, Tohru, Tobisawa, Yuki
格式: Artigo
語言:Inglês
出版: Springer US 2014
主題:
Original Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006118/
https://ncbi.nlm.nih.gov/pubmed/24700028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-014-0949-9
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍